You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2026

AbstractFullPdf
Oct 202033333382
Nov 2020878642
Dec 2020606042
Jan 2021636323
Feb 2021383818
Mar 2021595943
Apr 2021666631
May 2021414129
Jun 2021303015
Jul 2021313116
Aug 2021424228
Sep 2021262618
Oct 2021363635
Nov 2021313029
Dec 2021444422
Jan 202240417
Feb 2022161610
Mar 2022333725
Apr 2022333517
May 2022293014
Jun 2022515617
Jul 202236398
Aug 2022505014
Sep 2022272716
Oct 2022454719
Nov 2022383817
Dec 2022282816
Jan 202326266
Feb 202337377
Mar 2023272821
Apr 202317178
May 202318184
Jun 202313137
Jul 2023171715
Aug 202312136
Sep 202320215
Oct 202319198
Nov 2023292911
Dec 2023525211
Jan 2024181910
Feb 2024141410
Mar 2024272752
Apr 2024272718
May 202436348
Jun 2024282710
Jul 2024202111
Aug 2024181949
Sep 2024272713
Oct 2024272716
Nov 2024192012
Dec 2024424223
Jan 2025292935
Feb 202516168
Mar 2025343421
Apr 2025474723
May 2025212213
Jun 2025252515
Jul 2025110
Mar 2026110
Total217721981109